High-flow nasal cannula therapy reduced intubation rates in critically ill Pneumocystis pneumonia patients, though survival benefits were not observed, in a multicenter retrospective analysis.

PJP was associated with high mortality and low prophylaxis rates among immunocompromised patients without HIV infection.

T-cell therapy and bispecific antibodies are transforming multiple myeloma care, with earlier use, expanded community access, and outpatient delivery models offering opportunities to improve value, ...

Read the latest research on pneumonia, including how it is contracted, new treatments and more.